Skip to content

PLSM

Pulsenmore Ltd.

NASDAQ · Healthcare · Medical - Devices · IL

$2.22
−8.45%
Ask drillr

Year over year

Reported trailing growth

Revenue
+387.3%
EBITDA
+23.1%
EBIT
+34.7%
EPS
-2.2%
Free cash flow
-62.1%
Operating cash flow
-63.7%

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
+55.8%
EBITDA
+61.8%
EBIT
+71.1%
Net income
+56.7%
EPS
+56.7%
Free cash flow
+3.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026